Bicara Therapeutics

Bicara Therapeutics

A clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. .

HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$475m
Enterprise value
$14m
Share price
$9.29 BCAX
Authorizing premium user...